Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5207823
Max Phase: Preclinical
Molecular Formula: C23H17N5
Molecular Weight: 363.42
Associated Items:
ID: ALA5207823
Max Phase: Preclinical
Molecular Formula: C23H17N5
Molecular Weight: 363.42
Associated Items:
Canonical SMILES: c1ccc(-c2nnc(Cc3c[nH]c4cnccc34)nc2-c2ccccc2)cc1
Standard InChI: InChI=1S/C23H17N5/c1-3-7-16(8-4-1)22-23(17-9-5-2-6-10-17)28-27-21(26-22)13-18-14-25-20-15-24-12-11-19(18)20/h1-12,14-15,25H,13H2
Standard InChI Key: WARHJDZPKXMNNL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 363.42 | Molecular Weight (Monoisotopic): 363.1484 | AlogP: 4.67 | #Rotatable Bonds: 4 |
Polar Surface Area: 67.35 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.43 | CX LogP: 4.20 | CX LogD: 4.19 |
Aromatic Rings: 5 | Heavy Atoms: 28 | QED Weighted: 0.50 | Np Likeness Score: -0.67 |
1. Mahindra A, Jenkins L, Marsango S, Huggett M, Huggett M, Robinson L, Gillespie J, Rajamanickam M, Morrison A, McElroy S, Tikhonova IG, Milligan G, Jamieson AG.. (2022) Investigating the Structure-Activity Relationship of 1,2,4-Triazine G-Protein-Coupled Receptor 84 (GPR84) Antagonists., 65 (16.0): [PMID:35948061] [10.1021/acs.jmedchem.2c00804] |
Source(1):